» Articles » PMID: 39463026

A Critical Appraisal of the International Classification of Headache Disorders Migraine Diagnostic Criteria Based on a Retrospective Multicenter Cross-sectional Headache Registry Study in Youth

Overview
Journal Headache
Publisher Wiley
Specialties Neurology
Psychiatry
Date 2024 Oct 28
PMID 39463026
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We used Cluster Analysis of Migraine-associated Symptoms (CAMS) to critically evaluate current International Classification of Headache Disorders-Third Edition (ICHD-3) migraine-associated symptoms criteria.

Background: Diagnostic criteria play a central role in guiding clinical trial inclusion, and therefore available treatments. Migraine and tension-type headaches (TTH) are differentiated in ICHD-3 by many headache characteristics, including associated symptoms. A diagnosis of probable migraine indicates some but not all features of migraine are met. Photophobia and phonophobia, or nausea and/or vomiting, are required to meet a diagnosis of migraine; however, CAMS-a model that describes associated symptoms across youth with headache-indicates that a broader range of symptoms contain information about migraine burden.

Methods: In this multisite retrospective cross-sectional study, we evaluated ICHD-3 migraine criteria. Youth aged 6-17 years with migraine (including probable migraine) or TTH were included in the analysis. We used CAMS to evaluate the migraine-associated symptom criterion. With CAMS as a guide, we evaluated how changes to the migraine-associated symptom criterion altered who met the diagnosis of migraine.

Results: Of the 9017 participants included in this study, 66.7% were female and had a median (interquartile range) age of 13 (10-15) years. Most participants had migraine or probable migraine (99.0%), and the remainder had TTH (1.0%). A sizable percentage (10.1%) of youth under the umbrella diagnosis of migraine were diagnosed with probable migraine because they did not meet migraine-associated symptom criterion D; however, many in this group reported several non-ICHD migraine-associated symptoms. We explored alterations to criterion D based on CAMS. Allowing for photophobia or phonophobia re-categorized 55.6% of youth as having migraine, though some only had one symptom. Including lightheadedness or lightheadedness and spinning re-categorized 19.7% and 25.8% of youth with migraine, respectively, but all of those who were re-categorized had at least two migraine-associated symptoms.

Conclusion: The ICHD-3 captures the most prevalent migraine-associated symptoms; however, many youths with probable migraine who do not meet full criteria due to insufficient associated symptoms nonetheless experience multiple non-ICHD migraine-associated symptoms. Changes to criterion D should be considered for the ICHD-4.

Citing Articles

Cluster Analysis of Migraine-associated Symptoms (CAMS) in youth: A retrospective cross-sectional multicenter study.

Gentile C, Szperka C, Hershey A Headache. 2024; 64(10):1230-1243.

PMID: 39463035 PMC: 11560594. DOI: 10.1111/head.14859.

References
1.
Goadsby P . Recent advances in the diagnosis and management of migraine. BMJ. 2006; 332(7532):25-9. PMC: 1325129. DOI: 10.1136/bmj.332.7532.25. View

2.
Lipton R, Cady R, Stewart W, Wilks K, Hall C . Diagnostic lessons from the spectrum study. Neurology. 2002; 58(9 Suppl 6):S27-31. DOI: 10.1212/wnl.58.9_suppl_6.s27. View

3.
Turner D, Smitherman T, Black A, Penzien D, Porter J, Lofland K . Are migraine and tension-type headache diagnostic types or points on a severity continuum? An exploration of the latent taxometric structure of headache. Pain. 2015; 156(7):1200-1207. PMC: 4524296. DOI: 10.1097/j.pain.0000000000000157. View

4.
Gentile C, Aguirre G, Hershey A, Szperka C . Symptoms associated with headache in youth. Cephalalgia. 2023; 43(7):3331024231187162. PMC: 10852031. DOI: 10.1177/03331024231187162. View

5.
Silberstein S, Loder E, Diamond S, Reed M, Bigal M, Lipton R . Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia. 2007; 27(3):220-9. DOI: 10.1111/j.1468-2982.2006.01275.x. View